2019 tables: Institutions - biological sciences - corporate

The 2019 tables are based on Nature Index data from 1 January 2018 to 31 December 2018.

Table criteria

Request a badge Export CSV
# Institution Share 2017 Share 2018 Count 2018 Change in Adjusted Share* 2017–2018
1 BGI, China 6.05 4.96 27 -23.2%
2 Takeda Pharmaceutical Company Limited, Japan 5.22 4.45 17 -20.2%
3 Formosa Plastics Group, Taiwan 5.61 4.16 16 -30.6%
4 Eisai Co., Ltd., Japan 3.62 3.20 16 -17.2%
5 Samsung Group, South Korea 2.96 1.66 20 -47.4%
6 GNS Science, New Zealand 0.83 1.44 6 62.2%
7 Sosei Co., Ltd., Japan 1.58 1.36 6 -19.1%
8 Advanced Telecommunications Research Institute International (ATR), Japan 1.04 1.31 4 18.0%
9 Tata Group, India 0.03 1.26 2 4516.3%
10 Astellas Pharma Inc., Japan 0.00 1.23 7 36424.3%
11 The New Zealand Institute for Plant and Food Research Ltd., New Zealand 0.73 1.02 15 31.9%
12 ToolGen, Inc., South Korea 0.62 1.02 2 54.0%
13 WuXi AppTec, China 0.46 0.99 12 102.3%
14 Novogene Co., Ltd., China – 0.95 7 N/A
15 China National Petroleum Corporation (CNPC), China – 0.79 2 N/A
16 Health and Kampo Institute, Japan – 0.67 1 N/A
17 China National Chemical Corporation (ChemChina), China 1.20 0.64 4 -50.4%
18 Geneplus-Beijing Institute, China – 0.60 2 N/A
19 China State Shipbuilding Corporation Limited (CSSC), China 0.68 0.58 23 -20.2%
20 Daiichi Sankyo Co., Ltd., Japan 0.29 0.58 7 85.0%
21 Takara Bio Inc., Japan 0.02 0.57 3 3137.3%
22 Kowa Company, Ltd., Japan 0.00 0.55 6 16357.3%
23 AmorePacific Corporation, South Korea 0.05 0.55 1 1023.8%
24 Metabolomics Australia (MA), Australia 0.30 0.54 4 67.4%
25 CSL Limited, Australia 0.14 0.52 3 243.4%
26 LKK Health Products Group Ltd., China 0.02 0.51 3 2192.3%
27 FujiFilm Corporation, Japan 0.06 0.50 7 705.5%
28 Amine Pharma Research Institute Co., Ltd., Japan – 0.50 1 N/A
29 Toyota Group, Japan 0.71 0.47 1 -38.8%
30 Toray Industries, Inc., Japan 0.03 0.46 7 1222.3%
31 Olympus Corporation, Japan 0.05 0.43 1 662.6%
31 3D Medicines Inc., China – 0.43 1 N/A
32 Hayashibara Co., Ltd., Japan – 0.42 1 N/A
33 Nippon Shokubai Co., Ltd., Japan – 0.40 1 N/A
34 Tokuyama Corporation, Japan 0.33 0.38 1 5.4%
35 Miraca Holdings Inc., Japan 0.32 0.37 13 5.8%
36 Kyodo Milk Industry Co., Ltd., Japan – 0.36 1 N/A
37 Immuno-Biological Laboratories Co., Ltd., Japan 0.33 0.33 1 -6.3%
38 Thinkcyte Inc., Japan – 0.32 1 N/A
39 Nextomics Biosciences Co., Ltd., China – 0.31 2 N/A
40 Iflytek Co., Ltd., China – 0.30 1 N/A
41 C&K Genomics Inc., South Korea – 0.28 1 N/A
42 Guangzhou Henovcom Bioscience Co. Ltd., China – 0.27 1 N/A
43 Shanghai Bioray Laboratory Inc. (BRL), China 0.07 0.27 3 272.5%
44 Otsuka Holdings Co., Ltd., Japan 0.48 0.26 9 -48.7%
45 Shenzhen Mindray Bio-Medical Electronics Co., Ltd., China – 0.26 1 N/A
45 EVOC Intelligent Technology Company Limited, China – 0.26 1 N/A
46 Repertoire Genesis Inc., Japan 0.04 0.26 2 455.6%
47 Asahi Kasei Corporation, Japan 0.51 0.26 2 -52.2%
48 Fosun Orinove PharmaTech Inc., China – 0.26 3 N/A
49 Marine Works Japan Ltd., Japan – 0.25 1 N/A
50 Kirin Holdings Company Limited, Japan 0.61 0.25 6 -62.4%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals through 2022, in 2023 64 health-science journals were added to the Index. The 146 journals in the Nature Index were selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.
  5. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2022 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.